
Pension funds will be able to compare the performance of fiduciary managers for the first time after the UK’s antitrust regulator signed off new metrics, reported The Financial Times.
Fiduciary managers, which offer an asset management-type service and oversee the investment of £172 billion (US$229.4 billion) in assets for retirement funds, have been subjected to intense scrutiny for four years, including an investigation by the UK financial regulator and later the Competition and Markets Authority (CMA).
The new Global Investment Performance Standards, which were approved by the CMA this month, come in the wake of the antitrust regulator’s probe. The initiative will mean that fiduciary managers are no longer able to cherry-pick performance data to make it as attractive as possible to potential pension fund clients.
Iain McAra, director of the Global Investment Performance Standards at CFA Institute, which will oversee the new metrics, said the initiative was good news for pension funds across the UK.
“It was very, very difficult for prospective clients to compare fiduciary managers. They got a very different set of information from each fiduciary manager,” he said. “Now pension schemes are going to get exactly the same information from each fiduciary manager and therefore can make better decisions.”
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas